Javier Naranjo

Senior Counsel, Product & Commercial at hims & hers

Javier Naranjo is an experienced legal professional currently serving as Senior Commercial Counsel at hims & hers since April 2021, previously holding roles including Senior Counsel, Product & Commercial and Commercial Counsel. At Tailored Brands, Inc., from January 2018 to April 2021, Javier served as Senior Corporate Counsel, identifying legal and business risks while advising C-Suite executives on strategic agreements, including trademark licensing and joint ventures. Earlier, Javier was Vice President, Legal Counsel at Tropical Fruit Trading, Inc., where responsibilities included regulatory compliance and litigation management, and held the position of Corporate Counsel at California American Water, managing proceedings before the CPUC. Javier's legal career includes experience as Appeals Analyst at the Office of Natural Resources Revenue and various roles that involved legal research and analysis. Academically, Javier holds a Juris Doctorate and a Master's in International Politics from American University, along with a Bachelor's degree in Broadcast Journalism.

Links


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


hims & hers

34 followers

Hims & Hers Health, Inc. (better known as Hims & Hers) is a multi-specialty telehealth platform building a virtual front door to the healthcare system. Hims & Hers connects consumers to licensed healthcare professionals, enabling people to access high-quality medical care—from wherever is most convenient—for numerous conditions related to primary care, mental health, sexual health, skincare, and more. Launched in November 2017, the platform also offers thoughtfully created and curated health and wellness products. With products and services available across all 50 states and Washington, D.C., Hims & Hers’ mission is to make it easier for all Americans to access affordable care and treatment for conditions that impact their daily lives. In January 2021, the company was listed on the NYSE at an initial valuation of $1.6 billion and is traded under the ticker symbol “HIMS”.



This is an unverified company page